Do the Biorisk Evaluations of AI Labs Actually Measure the Risk of Developing Bioweapons?
BlueDot Narrated
00:00
Opacity of Non‑Benchmark Evaluations
Perrin Walker explains that many red team and uplift trials lack methodological detail and clear thresholds.
Play episode from 12:45
Transcript
